v3.25.2
Equity Incentive Plans (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Changes in Shares Available for Grant

Changes in shares available for grant during the six months ended June 30, 2025 were as follows:

 

 

 

Shares Available for Grant

 

Shares available for grant at December 31, 2024

 

 

18,018,312

 

Stock options, restricted stock units and performance-based restricted stock units granted and the maximum market-based restricted stock units granted eligible to be earned

 

 

(8,031,976

)

Stock options, restricted stock units and market-based restricted stock units forfeited or expired

 

 

1,398,109

 

Shares available for grant at June 30, 2025

 

 

11,384,445

 

Summary of Stock Option Activity Under 2009 Plan and 2019 Plan

Stock option activity under the 2009 Plan and 2019 Plan during the six months ended June 30, 2025 was as follows:

 

 

 

Shares Subject to
Outstanding Stock Options

 

 

Weighted-Average Exercise
Price per Share

 

 

Aggregate Intrinsic Value
(in thousands)

 

Stock options outstanding at December 31, 2024

 

 

12,295,297

 

 

$

15.11

 

 

 

 

Stock options granted

 

759,724

 

 

 

8.12

 

 

 

 

Stock options forfeited

 

 

(203,886

)

 

 

8.77

 

 

 

 

Stock options expired

 

 

(336,998

)

 

 

21.51

 

 

 

 

Stock options exercised

 

 

(1,120,704

)

 

 

6.30

 

 

 

 

Stock options outstanding at June 30, 2025

 

 

11,393,433

 

 

$

15.43

 

 

$

29,364

 

Stock options vested and exercisable at June 30, 2025

 

9,385,784

 

 

$

16.93

 

 

$

22,055

 

Summary of Restricted Stock Unit and Market-Based Restricted Stock Units Activity

Restricted stock unit activity under the 2019 Plan during the six months ended June 30, 2025 was as follows:

 

 

 

Restricted Stock Units
Outstanding

 

 

Weighted-Average Grant Date
Fair Value per Share

 

Nonvested restricted stock units outstanding at December 31, 2024

 

 

10,174,852

 

 

$

7.20

 

Restricted stock units granted

 

5,127,276

 

 

 

8.13

 

Restricted stock units forfeited

 

 

(610,108

)

 

 

7.62

 

Restricted stock units vested

 

 

(3,093,207

)

 

 

8.29

 

Nonvested restricted stock units outstanding at June 30, 2025

 

 

11,598,813

 

 

$

7.30

 

Market-based restricted stock unit activity under the 2019 Plan during the six months ended June 30, 2025 was as follows:

 

 

 

Maximum Market-Based Restricted
Stock Units Outstanding

 

 

Weighted-Average Grant Date
Fair Value per Share

 

Nonvested maximum market-based restricted stock units outstanding at December 31, 2024

 

 

3,831,114

 

 

$

10.80

 

Maximum market-based restricted stock units granted

 

 

2,020,000

 

 

 

13.50

 

Portion of maximum market-based restricted stock units that was not earned and vested at the end of the performance period, and therefore forfeited

 

 

(247,117

)

 

 

18.89

 

Market-based restricted stock units vested

 

 

(247,117

)

 

 

18.89

 

Nonvested maximum market-based restricted stock units outstanding at June 30, 2025

 

 

5,356,880

 

 

$

11.07

 

Summary of Estimated Grant Date Fair Values of Stock Options Granted

The estimated grant date fair values of stock options granted during the six months ended June 30, 2025 and 2024 were estimated using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

Six Months Ended June 30,

 

 

2025

 

2024

Fair value of common stock

 

$8.12

 

$3.99

Expected term (in years)

 

5.27 - 6.08

 

5.27 - 6.08

Risk-free interest rate

 

4.0% - 4.1%

 

4.2%

Expected volatility

 

74.2% - 74.7%

 

74.5% - 75.0%

Expected dividend yield

 

 

Summary of Compensation Costs Related to Stock Options and RSUs Included on Unaudited Condensed Consolidated Statements of Operations

The compensation cost related to stock options, restricted stock units, performance-based restricted stock units and market-based restricted stock units for the three and six months ended June 30, 2025 and 2024, respectively, are included on the unaudited condensed consolidated statements of operations as follows (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

1,010

 

 

$

1,011

 

 

$

1,889

 

 

$

1,917

 

Research and development

 

 

4,276

 

 

 

4,170

 

 

 

8,334

 

 

 

8,854

 

Sales and marketing

 

 

3,508

 

 

 

3,177

 

 

 

6,652

 

 

 

6,190

 

General and administrative

 

 

4,565

 

 

 

4,600

 

 

 

8,631

 

 

 

10,295

 

Total share-based compensation expense

 

$

13,359

 

 

$

12,958

 

 

$

25,506

 

 

$

27,256

 

Schedule of Unrecognized Share-Based Compensation Expense and the Remaining Weighted-Average Recognition Period

As of June 30, 2025, unrecognized share-based compensation expense and the remaining weighted-average recognition period were as follows:

 

 

 

Unrecognized Share-Based
Compensation Expense
(in thousands)

 

 

Remaining Weighted-Average
Recognition Period
(in years)

 

Nonvested stock options

 

$

10,373

 

 

 

2.03

 

Nonvested restricted stock units

 

 

72,339

 

 

 

2.79

 

Nonvested market-based restricted stock units

 

 

17,859

 

 

 

2.24